Top Story

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014

Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common share, in the third quarter of last year, according to a press release.

Total revenues were $0.4 million in the third quarter, an increase from $2,500 in total revenues the year before.

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities…

NIH renews research grants on aging

November 20, 2014
The NIH has announced renewed funding of $23.4 million for 11 Edward R. Roybal Centers for Research on Applied Gerontology and the designation of two additional…

Optos reports 7% increase in third-quarter revenue

November 20, 2014
Optos totaled $170.6 million in revenue and operating income in the third quarter, a 7% increase from $159.5 million in the third quarter 2013, according to a press…
More News Headlines »
Original Article

Influences of Topical Cyclopentolate on Anterior Chamber Parameters With a Dual-Scheimpflug Analyzer in Healthy Children

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, November 19, 2014
To evaluate the changes of anterior segment parameters following the topical instillation of cyclopentolate…
More »
CME
IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD

IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

The damage associated with age-related macular degeneration begins before visual symptoms occur, making early diagnosis…
More »
Meeting News Coverage Video

Surgeon says now is good time to adopt femtosecond cataract surgery

November 19, 2014
NEW YORK — At OSN New York, John A. Hovanesian, MD, discusses reasons that he has begun performing femtosecond…
More »
morganatic-roan